RBC Capital analyst Kenneth Lee maintains Chimera Investment (NYSE:CIM) with a Outperform and lowers the price target from $7 to $6.
RBC Capital Maintains Outperform on Chimera Investment, Lowers Price Target to $6
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.